Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.400 | None | 0.944 | 14 | 0 | 1991 | 2018 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
disease | 0.360 | None | 0.857 | 5 | 0 | 1995 | 2018 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.330 | None | 1.000 | 2 | 0 | 2004 | 2018 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 1992 | 2018 | ||||||||
|
carbonic anhydrase 9 | 0.483 | 0.731 | 1.3E-09 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2010 | 2012 | ||||||||
|
BCAR1 scaffold protein, Cas family member | 0.518 | 0.846 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2013 | 2018 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.100 | None | 0.962 | 48 | 0 | 1988 | 2020 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1997 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 9 | 1 | 2007 | 2019 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1999 | 2015 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.060 | None | 1.000 | 6 | 1 | 1997 | 2018 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1994 | 2015 | ||||||||
|
lamin A/C | 0.384 | 0.885 | 1.00 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2008 | 2018 | ||||||||
|
progesterone receptor | 0.426 | 0.885 | 5.1E-02 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2002 | 2018 | ||||||||
|
tumor protein p63 | 0.362 | 0.769 | 1.00 |
|
disease | 0.050 | None | 0.800 | 4 | 0 | 2001 | 2016 | ||||||||
|
retinoid isomerohydrolase RPE65 | 0.417 | 0.808 | 6.5E-14 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2001 | 2016 | ||||||||
|
cytoskeleton associated protein 4 | 0.436 | 0.731 | 0.51 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2001 | 2016 | ||||||||
|
sulfotransferase family 4A member 1 | 0.700 | 0.346 | 0.97 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2008 | 2012 | ||||||||
|
UV radiation resistance associated | 0.436 | 0.769 | 0.99 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2001 | 2016 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2010 | 2015 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.040 | None | 1.000 | 3 | 0 | 2003 | 2007 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.040 | None | 1.000 | 3 | 0 | 2002 | 2012 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2000 | 2018 | ||||||||
|
proliferating cell nuclear antigen | 0.382 | 0.846 | 0.98 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1994 | 2004 | ||||||||
|
DNA methyltransferase 1 | 0.406 | 0.885 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2005 | 2014 |